Mesoblast (MESO) Change in Receivables (2016 - 2023)

Mesoblast (MESO) posted quarterly Change in Receivables of $9000.0 for Q1 2023, down 97.81% year-on-year from $411000.0 in Q1 2022, and up 100.71% on a QoQ basis from -$1.3 million in Q4 2022.

Mesoblast (MESO) Change in Receivables (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has reported Change in Receivables for 8 consecutive years, with $9000.0 the latest figure, recorded in Q1 2023.

  • Quarterly Change in Receivables fell 97.81% year-over-year to $9000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $499000.0 (up 132.79% YoY) and the FY2022 annual result came in at $140000.0, up 108.05% from the prior year.
  • Change in Receivables climbed to $9000.0 in Q1 2023 per MESO's latest filing, from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for MESO reached as high as $14.8 million in Q4 2019 and fell as low as -$15.4 million in Q3 2019.
  • A 5-year average of -$97294.1 and a median of $9000.0 in 2023 frame the typical range for Change in Receivables.
  • Annual changes were most pronounced in 2021 — Change in Receivables soared 551.56% — and 2022, when it slumped 197.64%.
  • Year by year, Change in Receivables stood at $14.8 million in 2019, then sank by 105.81% to -$858000.0 in 2020, then jumped by 50.58% to -$424000.0 in 2021, then sank by 197.64% to -$1.3 million in 2022, then soared by 100.71% to $9000.0 in 2023.
  • According to Business Quant data, Change in Receivables over the past three periods registered $9000.0, -$1.3 million, and $519000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 75.30 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.84 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mesoblast 2.08 Bn 1.95 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 9,000.00
Mar 31, 2023 9,000.00
Dec 31, 2022 -1.26 Mn
Dec 31, 2022 -1.26 Mn
Sep 30, 2022 519,000.00
Sep 30, 2022 519,000.00
Jun 30, 2022 1.23 Mn
Jun 30, 2022 1.23 Mn
Mar 31, 2022 411,000.00
Mar 31, 2022 411,000.00
Dec 31, 2021 -424,000.00
Dec 31, 2021 -424,000.00
Sep 30, 2021 -1.08 Mn
Sep 30, 2021 -1.08 Mn
Jun 30, 2021 -429,000.00
Jun 30, 2021 -429,000.00
Mar 31, 2021 417,000.00
Mar 31, 2021 417,000.00
Dec 31, 2020 -858,000.00
Dec 31, 2020 -858,000.00